Back to BlackRock, Inc. BlackRock, Inc.

NRIXNRIX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in NURIX THERAPEUTICS INC

BlackRock, Inc. holds 8.8M shares of NRIX (NURIX THERAPEUTICS INC), worth $212.8M as of 2026-Q2. The position was decreased (-1.7% shares). NRIX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$212.8M

Current Shares

8.8M

Total Value Change

+$68.2M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
8.8M
-1.7%
$212.8M0.0%$24.26
0
2026-Q1
Increased
8.9M
+0.6%
$138.3M0.0%$15.81
30
2025-Q4
Increased
8.9M
+31.2%
$168.4M0.0%$19.02
39
2025-Q3
Decreased
6.8M
-0.7%
$62.5M0.0%$9.28
0
2025-Q2
Decreased
6.8M
-14.7%
$77.6M0.0%$11.64
0
2025-Q1
Increased
8M
+4.0%
$94.9M0.0%$12.15
31
2024-Q4
New
7.7M
-
$144.6M0.0%$18.64
42

Other major holders of NRIX: FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used